242 related articles for article (PubMed ID: 32023463)
1. Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.
AlAbdi L; Saha D; He M; Dar MS; Utturkar SM; Sudyanti PA; McCune S; Spears BH; Breedlove JA; Lanman NA; Gowher H
Cell Rep; 2020 Feb; 30(5):1478-1490.e6. PubMed ID: 32023463
[TBL] [Abstract][Full Text] [Related]
2. An epigenetic switch regulates de novo DNA methylation at a subset of pluripotency gene enhancers during embryonic stem cell differentiation.
Petell CJ; Alabdi L; He M; San Miguel P; Rose R; Gowher H
Nucleic Acids Res; 2016 Sep; 44(16):7605-17. PubMed ID: 27179026
[TBL] [Abstract][Full Text] [Related]
3. LSD1-mediated demethylation of OCT4 safeguards pluripotent stem cells by maintaining the transcription of PORE-motif-containing genes.
Dan S; Song Y; Duan X; Pan X; Chen C; She S; Su T; Li J; Chen X; Zhou Y; Chen W; Zhang X; Pan X; Wang YJ; Kang B
Sci Rep; 2021 May; 11(1):10285. PubMed ID: 33986438
[TBL] [Abstract][Full Text] [Related]
4. Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion.
Shakya A; Callister C; Goren A; Yosef N; Garg N; Khoddami V; Nix D; Regev A; Tantin D
Mol Cell Biol; 2015 Mar; 35(6):1014-25. PubMed ID: 25582194
[TBL] [Abstract][Full Text] [Related]
5. Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency.
Choi HW; Joo JY; Hong YJ; Kim JS; Song H; Lee JW; Wu G; Schöler HR; Do JT
Stem Cell Reports; 2016 Nov; 7(5):911-926. PubMed ID: 28157483
[TBL] [Abstract][Full Text] [Related]
6. An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells.
Cao K; Collings CK; Morgan MA; Marshall SA; Rendleman EJ; Ozark PA; Smith ER; Shilatifard A
Sci Adv; 2018 Jan; 4(1):eaap8747. PubMed ID: 29404406
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
Freberg CT; Dahl JA; Timoskainen S; Collas P
Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
[TBL] [Abstract][Full Text] [Related]
8. LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16.
Yin F; Lan R; Zhang X; Zhu L; Chen F; Xu Z; Liu Y; Ye T; Sun H; Lu F; Zhang H
Mol Cell Biol; 2014 Jan; 34(2):158-79. PubMed ID: 24190971
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
10. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
Barrand S; Collas P
Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 1 Promotes Deacetylation of Oct4 and Maintenance of Naive Pluripotency.
Williams EO; Taylor AK; Bell EL; Lim R; Kim DM; Guarente L
Cell Rep; 2016 Oct; 17(3):809-820. PubMed ID: 27732856
[TBL] [Abstract][Full Text] [Related]
12. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.
Wang J; Lu F; Ren Q; Sun H; Xu Z; Lan R; Liu Y; Ward D; Quan J; Ye T; Zhang H
Cancer Res; 2011 Dec; 71(23):7238-49. PubMed ID: 21975933
[TBL] [Abstract][Full Text] [Related]
13. Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming.
Chen J; Chen X; Li M; Liu X; Gao Y; Kou X; Zhao Y; Zheng W; Zhang X; Huo Y; Chen C; Wu Y; Wang H; Jiang C; Gao S
Cell Rep; 2016 Feb; 14(6):1540-1554. PubMed ID: 26832419
[TBL] [Abstract][Full Text] [Related]
14. A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4.
Smith JA; Ndoye AM; Geary K; Lisanti MP; Igoucheva O; Daniel R
Aging Cell; 2010 Aug; 9(4):580-91. PubMed ID: 20477760
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells.
Lin Y; Yang Y; Li W; Chen Q; Li J; Pan X; Zhou L; Liu C; Chen C; He J; Cao H; Yao H; Zheng L; Xu X; Xia Z; Ren J; Xiao L; Li L; Shen B; Zhou H; Wang YJ
Mol Cell; 2012 Nov; 48(4):627-40. PubMed ID: 23041284
[TBL] [Abstract][Full Text] [Related]
16. Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions.
Favaedi R; Shahhoseini M; Akhoond MR
Mol Cell Biochem; 2012 Apr; 363(1-2):129-34. PubMed ID: 22160855
[TBL] [Abstract][Full Text] [Related]
17. Simplified MethylRAD Sequencing to Detect Changes in DNA Methylation at Enhancer Elements in Differentiating Embryonic Stem Cells.
Saha D; Norvil AB; Lanman NA; Gowher H
Epigenomes; 2020 Dec; 4(4):. PubMed ID: 33828860
[TBL] [Abstract][Full Text] [Related]
18. LSD1 Mediates Neuronal Differentiation of Human Fetal Neural Stem Cells by Controlling the Expression of a Novel Target Gene, HEYL.
Hirano K; Namihira M
Stem Cells; 2016 Jul; 34(7):1872-82. PubMed ID: 27018646
[TBL] [Abstract][Full Text] [Related]
19. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
20. GR and LSD1/KDM1A-Targeted Gene Activation Requires Selective H3K4me2 Demethylation at Enhancers.
Clark EA; Wu F; Chen Y; Kang P; Kaiser UB; Fang R; Shi YG
Cell Rep; 2019 Jun; 27(12):3522-3532.e3. PubMed ID: 31216473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
